Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress

Journal of Neurochemistry

Volumn 87, Issue 2, 2003, Pages 522-531

  Lewerenz, Jan ^a   Letz, Julia ^a   Methner, Axel ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bcl 2; Cholera toxin; G protein coupled receptor; Glutathione; HT22 cells; Oxidative stress

Indexed keywords

ANTIPORTER; BUTHIONINE SULFOXIMINE; CHOLERA TOXIN; CYSTINE; GLUTAMATE CYSTINE ANTIPORTER SUBUNIT XCT; GLUTATHIONE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROGEN PEROXIDE; PHORBOL ESTER; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ARTICLE; BRAIN CELL; CALCIUM TRANSPORT; CELL DEATH; CELL LINE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; NERVE CELL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; CARRIER PROTEINS; CELL DEATH; CELL LINE; CHOLERA TOXIN; CYCLIC AMP; GENE EXPRESSION REGULATION; GLUTAMIC ACID; GLUTATHIONE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HIPPOCAMPUS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 0141953294     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02019.x     Document Type: Article

References (66)

1. Bannai S. (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256-2263.
2. Bassi M. T., Gasol E., Manzoni M., Pineda M., Riboni M., Martin R., Zorzano A., Borsani G. and Palacin M. (2001) Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc. Pflugers Arch. 442, 286-296.
3. Beal M. F. (1996) Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6, 661-666.
4. Bond A., O'Neill M. J., Hicks C. A., Monn J. A. and Lodge D. (1998) Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport 9, 1191-1193.
5. Bruer U., Weih M. K., Isaev N. K. et al. (1997) Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. 414, 117-121.
6. Campbell V. A. (2001) Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation. Neuropharmacology 40, 702-709.
7. Chen C. J., Liao S. L. and Kuo J. S. (2000) Gliotoxic action of glutamate on cultured astrocytes. J. Neurochem. 75, 1557-1565.
8. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
9. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
10. Davies S. P., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
11. Davis J. B. and Maher P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169-173.
12. Ellerby L. M., Ellerby H. M., Park S. M. et al. (1996) Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67, 1259-1267.
13. Ferreira J. M. and Paes-de-Carvalho R. (2001) Long-term activation of adenosine A (2a) receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons. Brain Res. 900, 169-176.
14. Froissard P., Monrocq H. and Duval D. (1997) Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur. J. Pharmacol. 326, 93-99.
15. Gochenauer G. E. and Robinson M. B. (2001) Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L- [3H]glutamate transport and expression of both system xc (-) subunits. J. Neurochem. 78, 276-286.
16. Griffith O. W. (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
17. Griffith O. W. (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med. 27, 922-935.
18. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
19. Hansen M. B., Nielsen S. E. and Berg K. (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth. 119, 203-210.
20. Hui H., Nourparvar A., Zhao X. and Perfetti R. (2003) Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144, 1444-1455.
21. Ishige K., Chen Q., Sagara Y. and Schubert D. (2001) The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J. Neurosci. 21, 6069-6076.
22. Jolkkonen J., Puurunen K., Koistinaho J., Kauppinen R., Haapalinna A., Nieminen L. and Sivenius J. (1999) Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur. J. Pharmacol. 372, 31-36.
23. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Ord T. and Bredesen D. E. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
24. Katada T., Bokoch G. M., Smigel M. D., Ui M. and Gilman A. G. (1984) The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Subunit dissociation and the inhibition of adenylate cyclase in S49 lymphoma cyc- and wild type membranes. J. Biol. Chem. 259, 3586-3595.
25. Kimura M., Mizukami Y., Miura T., Fujimoto K., Kobayashi S. and Matsuzaki M. (2001) Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation. J. Biol. Chem. 276, 26453-26460.
26. von Knethen A., Lotero A. and Brune B. (1998) Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression. Oncogene 17, 387-394.
27. Li X., Hales K. H., Watanabe G., Lee R. J., Pestell R. G. and Hales D. B. (1997a) The effect of tumor necrosis factor-alpha and cAMP on induction of AP-1 activity in MA-10 tumor Leydig cells. Endocrine 6, 317-324.
28. Li Y., Maher P. and Schubert D. (1997b) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19, 453-463.
29. Li Y., Maher P. and Schubert D. (1997c) Requirement for cGMP in nerve cell death caused by glutathione depletion. J. Cell Biol. 139, 1317-1324.
30. Li Y., Maher P. and Schubert D. (1998) Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc. Natl. Acad. Sci. USA 95, 7748-7753.
31. Lopez-Ilasaca M., Crespo P., Pellici P. G., Gutkind J. S. and Wetzker R. (1997) Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275, 394-397.
32. Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 2929-2938.
33. Maher P. and Davis J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 6394-6401.
34. Mantamadiotis T., Lemberger T., Bleckmann S. C. et al. (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet. 31, 47-54.
35. Meister A. (1994) Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269, 9397-9400.
36. Meredith M. J., Cusick C. L., Soltaninassab S., Sekhar K. S., Lu S. and Freeman M. L. (1998) Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. Biochem. Biophys. Res. Commun. 248, 458-463.
37. Miyamoto M., Murphy T. H., Schnaar R. L. and Coyle J. T. (1989) Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250, 1132-1140.
38. Moinova H. R. and Mulcahy R. T. (1998) An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J. Biol. Chem. 273, 14683-14689.
39. Monnier D. and Loeffler J. P. (1998) Pituitary adenylate cyclase-activating polypeptide stimulates proenkephalin gene transcription through AP1- and CREB-dependent mechanisms. DNA Cell Biol. 17, 151-159.
40. Moss J. and Vaughan M. (1979) Activation of adenylate cyclase by choleragen. Annu. Rev. Biochem. 48, 581-600.
41. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L. and Coyle J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558.
42. Murphy T. H., Schnaar R. L. and Coyle J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. Faseb J. 4, 1624-1633.
43. O'Neill M. J., Hicks C. A., Ward M. A., Cardwell G. P., Reymann J. M., Allain H. and Bentue-Ferrer D. (1998) Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur. J. Pharmacol. 352, 37-46.
44. Oka A., Belliveau M. J., Rosenberg P. A. and Volpe J. J. (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 13, 1441-1453.
45. Pizzi M., Boroni F., Benarese M., Moraitis C., Memorandum M. and Spano P. (1999) Neuroprotective effect of thyrotropin-releasing hormone against excitatory amino acid-induced cell death in hippocampal slices. Eur. J. Pharmacol. 370, 133-137.
46. Pratico D. (2002) Alzheimer's disease and oxygen radicals: new insights. Biochem. Pharmacol. 63, 563-567.
47. Rahman I., Smith C. A., Lawson M. F., Harrison D. J. and MacNee W. (1996) Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett. 396, 21-25.
48. Rahman I., Smith C. A., Antonicelli F. and MacNee W. (1998) Characterisation of gamma-glutamylcysteine synthetase-heavy subunit promoter: a critical role for AP-1. FEBS Lett. 427, 129-133.
49. Ratan R. R., Murphy T. H. and Baraban J. M. (1994) Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62, 376-379.
50. Rezzonico R., Loubat A., Lallemand D., Pfarr C. M., Far D. F., Proudfoot A., Rossi B. and Ponzio G. (1995) Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines. Oncogene 11, 1069-1078.
51. Rothermel J. D., Perillo N. L., Marks J. S. and Botelho L. H. (1984) Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic-3′,5′ -phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase. J. Biol. Chem. 259, 15294-15300.
52. Sagara Y. and Schubert D. (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18, 6662-6671.
53. Sagara Y., Dargusch R., Chambers D., Davis J., Schubert D. and Maher P. (1998) Cellular mechanisms of resistance to chronic oxidative stress. Free Radic. Biol. Med. 24, 1375-1389.
54. Schmidt P., Holsboer F. and Spengler D. (2001) Beta (2)-adrenergic receptors potentiate glucocorticoid receptor transactivation via G protein beta gamma-subunits and the phosphoinositide 3-kinase pathway. Mol. Endocrinol. 15, 553-564.
55. Schubert D. and Piasecki D. (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J. Neurosci. 21, 7455-7462.
56. Sekhar K. R., Meredith M. J., Kerr L. D., Soltaninassab S. R., Spitz D. R., Xu Z. Q. and Freeman M. L. (1997) Expression of glutathione and gamma-glutamylcysteine synthetase mRNA is Jun dependent. Biochem. Biophys. Res. Commun. 234, 588-593.
57. Shoshan M. C., Ljungdahl S. and Linder S. (1996) H-89 inhibits collagenase induction by phorbol ester through a mechanism that does not involve protein kinase A. Cell Signal 8, 191-195.
58. Takei N., Skoglosa Y. and Lindholm D. (1998) Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons. J. Neurosci. Res. 54, 698-706.
59. Tan S., Wood M. and Maher P. (1998a) Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71, 95-105.
60. Tan S., Sagara Y., Liu Y., Maher P. and Schubert D. (1998b) The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423-1432.
61. Tan S., Schubert D. and Maher P. (2001a) Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497-506.
62. Tan S., Somia N., Maher P. and Schubert D. (2001b) Regulation of antioxidant metabolism by translation initiation factor 2 alpha. J. Cell Biol. 152, 997-1006.
63. Tietze F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
64. Voehringer D. W. and Meyn R. E. (2000) Redox aspects of Bcl-2 function. Antioxid Redox Signal 2, 537-550.
65. Yasui M. and Kawasaki K. (1995) CCKB receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rats hippocampal slices. Neurosci. Lett. 191, 99-102.
66. Yasui M., Zelenin S. M., Celsi G. and Aperia A. (1997) Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am. J. Physiol. 272, F443-F450.